Saba Capital Management, Reported A 5.31% Stake In abrdn Life Sciences

Tekla Life Sciences Investors of Benef Interest -1.44%

Tekla Life Sciences Investors of Benef Interest

HQL

13.01

-1.44%

-13D

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via